Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

CAT-8015 is evaluated in phase I trial in hairy cell leukemia

June 23, 2010

TH-302/doxorubicin combination is safe in phase I/II trial in soft tissue sarcoma

June 23, 2010

Phase II data support use of florbetaben to diagnose AD using PET

June 23, 2010

IMB-007 shows promise as neuropathic pain therapy

June 23, 2010

TC-5214 shows benefit as add-on to citalopram in major depression

June 23, 2010

Synergy seen with topiramate and amantadine in model of levodopa-induced dyskinesia

June 23, 2010

ALD-518 improves rheumatoid arthritis symptoms in phase II trial

June 22, 2010

177Lu-J591 shows safety and preliminary efficacy in metastatic CRPC

June 22, 2010

PX-478 shows antitumor activity in phase I trial in advanced solid tumors

June 22, 2010

Phase I/II trial of new proapoptotic agent APR-246 advances

June 22, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...